Streamline Health Solutions (NASDAQ:STRM) Second Quarter 2025 Results

Key Financial Results

• Revenue: US$4.48m (down 22% from 2Q 2024).
• Net loss: US$2.80m (loss widened by 12% from 2Q 2024).
• US$0.047 loss per share (further deteriorated from US$0.045 loss in 2Q 2024).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Streamline Health Solutions Revenues Beat Expectations, EPS Falls Short

Revenue exceeded analyst estimates by 3.3%. Earnings per share (EPS) missed analyst estimates by 25%.

Looking ahead, revenue is forecast to grow 9.9% p.a. on average during the next 3 years, compared to a 9.9% growth forecast for the Healthcare Services industry in the US.

Performance of the American Healthcare Services industry.

The company's shares are down 58% from a week ago.

Risk Analysis

Be aware that Streamline Health Solutions is showing 4 warning signs in our investment analysis and 1 of those is concerning...

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.